GLA Borage Oil
Natural health product licensed in Canada
- Other names
- Skinsmart
- Licence holder
- Jamieson Laboratories Ltd./ Nutricorp International
- NPN or DIN-HM
- 80052170
- Status
- Active licence
- Licence date
- 2 July 2014
- Revision date
- 8 September 2026
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Borago officinalis L.: Les préparations de cette plante sont autorisées s'il peut être démontré qu'elles ne dépassent pas 1 ppb d'alcaloïdes pyrrolizidiniques.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Borago officinalis Source : Borago officinalis - Graine Potency : 240 mg gamma-Linolenic acid | 1,050 mg | Not calculated |
| Borago officinalis Source : Borago officinalis - Graine Potency : 456 mg Linoleic acid | Not specified | Not calculated |
Non-medicinal ingredients
Carraghénine, Amidon de maïs modifié, Eau purifiée, Extrait de pain de St-Jean-Baptiste, Caramel, Glycérine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 4 Capsule | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Source of essential fatty acids for the maintenance of good health. Source of omega-6 fatty acids for the maintenance of good health. Source of linoleic acid (LA) for the maintenance of good health. Used to help relieve symptoms of mild cases of atopic dermatitis (eczema). Helps improve the inflammatory symptoms of mild atopic dermatitis (eczema). Helps to improve symptoms such as roughness and redness associated with atopic dermatitis (eczema). Helps improve the symptoms of inflammatory skin conditions such as atopic dermatitis (eczema). Used to help relieve symptoms of mild cases of atopic dermatitis (eczema). Helps to maintain skin firmness. Helps to improve skin moisture. Helps to improve skin elasticity. Helps to reduce symptoms associated with acne. Helps to reduce skin inflammation associated with acne. Helps to maintain skin moisture. Helps to improve skin hydration. Helps to maintain skin elasticity.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80052170
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Has the product changed? Photograph the packaging.